SG Americas Securities
EW icon

SG Americas Securities’s Edwards Lifesciences EW Stock Holding History

SG Americas Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,000
Closed -$108K – 3555
2024
Q4 		$108K Hold
30,000
– – ﹤0.01% 2685
2024
Q3 		$320K Sell
30,000
-9,900
-25% -$719K ﹤0.01% 2090
2024
Q2 		$47K Buy
+39,900
New +$3.53M ﹤0.01% 2682
2016
Q2 		– Sell
-32,100
Closed -$21K – 2716
2016
Q1 		$21K Buy
+32,100
New +$886K ﹤0.01% 2837

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

SG Americas Securities's EW Position: Q2 2026 in Review

SG Americas Securities reduced its Edwards Lifesciences (EW) stake by 43% in Q2 2026, selling an estimated $35.3M and leaving 559,479 shares worth $50.6M. The position accounts for 0.03% of the portfolio, ranked #350.

SG Americas Securities first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $78.5M in Q1 2026. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • SG Americas Securities held 559,479 shares of Edwards Lifesciences worth $50.6M as of Q2 2026.
  • SG Americas Securities sold 421,130 Edwards Lifesciences shares in Q2 2026, an estimated $35.3M.
  • Edwards Lifesciences made up 0.03% of SG Americas Securities's portfolio in Q2 2026, its #350 holding.
  • SG Americas Securities first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
  • SG Americas Securities's Edwards Lifesciences position peaked at $78.5M in Q1 2026.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.